Key Metrics of Cencora
Revenue$262B▲ 9.9% YoYFY 2023
Operating income$2.3B▼ 1.1% YoY
Net profit$1.7B▲ 2.7% YoY
Shareholders' equity$912M
Market cap$64.6BCOR · $338.48
Competitors10identified
Open jobs2
About Cencora
Sectors
Company details
- Website
- cencora.com
- Listed
- NYSE: COR
Operational Areas of Cencora
Pharmaceuticals & Healthcare›Formulations & Contract Manufacturing
Company summary
Legal nameCencora Inc.
TickerCOR
ExchangeNYSE
CountryUnited States
SEC CIK0001140859
Listed since—
IndustryOther Pharmaceuticals
SectorPharmaceuticals & Healthcare · Formulations & Contract Manufacturing
Websitehttp://www.cencora.com
US market & SEC filings
COR · NYSE · SEC CIK 0001140859
Last price · 24 Oct 2026
$338.48
−0.57%
Market cap$64.6B
P/E39.7On FY 2023 diluted EPS
Volume1,183,280
SectorHealth CareOther Pharmaceuticals
Country · IPOUnited States
COR share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeChesterbrook
GSTIN—
Email—
Websitehttp://www.cencora.com
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Cencora
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | lilly.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | jjmt.com.tw | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pg.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | merck.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | amgen.com | 1983 | United States | |
| Part of Gilead Sciences. | gilead.com | 1992 | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | abbott.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | pfizer.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | bms.com | — | United States | |
| Formulations & Contract Manufacturing · Pharmaceuticals & Healthcare | marriott.com.cn | — | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Group companies
Business activities and related parties
pharmaceutical industry
Filings
No filings on record yet.